New Leaf venture team overview and investment history

New Leaf venture team overview and investment history The passage provides a corporate biography of the New Leaf senior partners and their investment track record. It contains no direct references to high‑ranking public officials, government agencies, or controversial financial flows, limiting its investigative value. While it lists specific companies and board memberships, there are no actionable leads, dates of wrongdoing, or connections to political power centers. Key insights: New Leaf manages multiple healthcare technology funds (NLV‑I, NLV‑II, etc.); Senior partner Philippe Chambon has extensive board roles in biotech firms; Historical fund sizes range from $204 M to $1.1 B across 1993‑2013